Last reviewed · How we verify
ciprofol
ciprofol is a Small molecule drug developed by Sichuan Provincial People's Hospital. It is currently FDA-approved. Also known as: haisco pharmaceutical group, CIP, 2-[(1R)-1-cyclopropylethyl]-6-isopropyl-phenol, Ciprofol injection.
Ciprofol is a small molecule that acts as a GABA-A receptor agonist, classified as an anesthetic. It is used for intravenous infusion in anesthesia and sedation, and is reportedly 4 to 6 times more potent than propofol.
At a glance
| Generic name | ciprofol |
|---|---|
| Also known as | haisco pharmaceutical group, CIP, 2-[(1R)-1-cyclopropylethyl]-6-isopropyl-phenol, Ciprofol injection, HSK3486 |
| Sponsor | Sichuan Provincial People's Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Correlating EEG Dynamics With Consciousness Alteration Under Anesthesia
- Effect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial (NA)
- A Study on Median Effective Concentration of Ciprofol Combined With Remifentanil Via Target-controlled Infusion for Inhibiting Tracheal Intubation Stimulation Under qNOX Index Monitoring (NA)
- Changes of Ciprofol Dosage and Bispectral Index Required for Loss of Consciousness in Patients of Different Ages
- Dynamic Effects of Different Anesthetic Agents on the Immune Function of Healthy Volunteers (NA)
- Efficacy and Safety of Anricofen Combined With Ciprofol for Deep Sedation in Elderly Patients Undergoing ERCP (NA)
- Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery (PHASE4)
- Efficacy and Safety of Ciprofol for General Anaesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ciprofol CI brief — competitive landscape report
- ciprofol updates RSS · CI watch RSS
- Sichuan Provincial People's Hospital portfolio CI
Frequently asked questions about ciprofol
What is ciprofol?
Who makes ciprofol?
Is ciprofol also known as anything else?
What development phase is ciprofol in?
Related
- Manufacturer: Sichuan Provincial People's Hospital — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: haisco pharmaceutical group, CIP, 2-[(1R)-1-cyclopropylethyl]-6-isopropyl-phenol, Ciprofol injection, HSK3486
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing